Maximizing Oligonucleotide Therapeutic Development: How They Work Blog Maximizing Oligonucleotide Therapeutic Development: How They Work This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…Certara2021 年 5 月 7 日
Planning a Health Canada PRCI Compliant Submission Blog Planning a Health Canada PRCI Compliant Submission How to set yourself up for a successful Health Canada PRCI submissionCertara2021 年 4 月 26 日
Simcyp Simulator Impacts 80+ Novel Drugs Blog Simcyp Simulator 影响了超过 80 种新药的开发 250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and…Certara2021 年 3 月 17 日
The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers Blog The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…Certara2021 年 2 月 22 日
Getting Gene Therapies to Patients Blog 为患者提供基因疗法 This blog discusses the challenges that drug developers face in getting patients access to cell…Certara2021 年 2 月 16 日
Why Consistency in Patient Safety Narratives is Crucial Blog Why Consistency in Patient Safety Narratives is Crucial “You would not be able to tell 40 different writers were authoring these. It looked…Certara2021 年 2 月 9 日
8 Tips for Successfully Developing Oligonucleotide Therapies Blog 成功开发寡核苷酸疗法的 8 条小贴士 By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…Certara2021 年 2 月 1 日
Dose Optimization using the Gene Therapy Virtual Twin Platform Blog 利用基因治疗虚拟双胞胎平台优化剂量 This blog explains how using the Gene Therapy Virtual Twin™ Platform can help optimize dosing…Certara2021 年 1 月 22 日
Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert Blog Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert One of the most exciting things about working in the pharmaceutical industry is the ability…Certara2020 年 12 月 16 日
Regulatory submissions and transactions with Health Canada Blog Regulatory submissions and transactions with Health Canada By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…Certara2020 年 11 月 19 日